Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis
Clinical trial NCT07602517 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07602517
- Sponsor
- NYU Langone Health
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-20
- Primary completion
- 2028-05-20
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.